Table 1.
Patient characterisitics
| CD38 status (n) | Median age in years (range) | ||||
|---|---|---|---|---|---|
| No. patients | Pos. | Neg. | n.d. | ||
| Healthy controls | 16 | 76 (65–92) | |||
| CLL (all Binet stages no Rx) | 24 | 9 | 11 | 4 | 74 (38–92) |
| Stage A | 7 | 2 | 4 | 1 | 74 (38–92) |
| Stage B | 8 | 2 | 3 | 3 | 61 (51–84) |
| Stage C | 9 | 5 | 4 | 0 | 74 (50–87) |
| Stage C + flu | 7 | 3 | 4 | 0 | 63 (56–86) |
| Stage C + post-flu | 6 | 2 | 1 | 3 | 74 (50–87) |
| Stage C + CLB | 3 | 1 | 2 | 0 | 81 (74–87) |
| Stage C + CHOP | 2 | 2 | 0 | 0 | 48 (35–61) |
Rx: treatment; Flu: fludarabine; CHOP: cyclophosphamide, hydroxydaunorubicin, oncovin, prednisolone; CLB: chlorambacil; Pos.: positive; neg.: negative; n.d.: not done; CLL: chronic lymphocytic leukaemia.